Global Threonine Acids Market Growth, Share, Size, Trends and Forecast (2025 - 2031)

By Product Type;

D-Threonine, L-Threonine, and Others.

By Sources;

Animal Based and Plant Based.

By Livestock;

Cattle, Swine, Poultry, Aquatic Animal, and Others.

By Application;

Food & Dietary Supplements, Animal Feed, Pharmaceuticals, and Others.

By Geography;

North America, Europe, Asia Pacific, Middle East & Africa, and Latin America - Report Timeline (2021 - 2031).
Report ID: Rn328452531 Published Date: May, 2025 Updated Date: June, 2025

Threonine Acids Market Overview

Threonine Acids Market (USD Million)

Threonine Acids Market was valued at USD 1,247.20 million in the year 2024. The size of this market is expected to increase to USD 1,671.85 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 4.3%.


Global Threonine Acids Market Growth, Share, Size, Trends and Forecast

*Market size in USD million

CAGR 4.3 %


Study Period2025 - 2031
Base Year2024
CAGR (%)4.3 %
Market Size (2024)USD 1,247.20 Million
Market Size (2031)USD 1,671.85 Million
Market ConcentrationHigh
Report Pages387
1,247.20
2024
1,671.85
2031

Major Players

  • Prinova Group LLC
  • Evonik Industries Corporation
  • Archer D&O Pharmachem Inc.,
  • Degussa Corporation
  • Shanghai Seebio Biotech, Inc.,
  • The Graymor Chemical Co.
  • Pharmline Inc.,
  • Yore Chemipharm Co., Ltd.,
  • Foodchem International Corporation,
  • Viachem Ltd.,
  • Peptides International Inc.,
  • Ajinomoto Heartland, Inc.,
  • Biomatik Corporation,

Market Concentration

Consolidated - Market dominated by 1 - 5 major players

Global Threonine Acids Market

Fragmented - Highly competitive market without dominant players


The Threonine Acids Market is witnessing robust growth as threonine becomes increasingly vital in animal nutrition and human wellness. As an essential amino acid, it plays a key role in protein synthesis and metabolic function, especially in livestock. With a surge of over 30% in demand for high-efficiency animal feed, threonine is being adopted more widely to boost productivity and health outcomes. This expansion reflects the rising preference for nutritionally optimized formulations in agriculture and healthcare.

Shift Towards Sustainable Manufacturing
Innovations in bio-based production are redefining the threonine supply chain. Modern fermentation technologies have led to a 25% improvement in production efficiency, replacing traditional chemical methods. These eco-conscious advancements support the growing demand for natural and clean-label additives, aligning with industry-wide sustainability goals. The shift is helping producers maintain cost-efficiency while meeting regulatory and ethical standards.

Health-Driven Product Diversification
Beyond livestock, threonine is gaining visibility in dietary supplements and pharmaceutical applications. It contributes to immune defense, liver detoxification, and muscular repair, making it a favored ingredient in wellness-oriented products. The functional food segment has grown by 28%, driven by consumer inclination toward health-enhancing nutritional support. This diversification is broadening threonine’s commercial footprint across new consumer segments.

Innovation Through Targeted Research
The industry is actively investing in R&D to create precision-based threonine applications. More than 15% of threonine sector revenue is channeled into developing customized blends, improving nutrient uptake, and enhancing synergistic benefits. These innovations are fostering species-specific feed solutions and tailored pharmaceutical products. As technology evolves, the market is set to unlock new possibilities through personalized nutrition strategies.

Quality Compliance and Regulatory Influence
Global compliance standards are tightening, prompting firms to enhance purity, traceability, and certification. Demand for products that meet GMP, ISO, and HACCP criteria has fueled a 20% rise in quality assurance investments. These regulatory mandates are streamlining market practices, building brand credibility, and increasing competition among manufacturers to deliver superior, standardized threonine solutions.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Product Type
    2. Market Snapshot, By Sources
    3. Market Snapshot, By Livestock
    4. Market Snapshot, By Application
    5. Market Snapshot, By Region
  4. Threonine Acids Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Rising demand for high-quality animal protein
        2. Growth in poultry and swine industries
        3. Expanding aquaculture sector
      2. Restraints
        1. Fluctuations in raw material prices
        2. Development of alternative feed additives
        3. Regulatory challenges
      3. Opportunities
        1. ALM market footprint expanding globally
        2. Innovations in feed formulation
        3. Increasing adoption of precision livestock farming
    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Competitive Rivalry

  5. Market Segmentation
    1. Threonine Acids Market, By Product Type, 2021 - 2031 (USD Million)
      1. D-Threonine
      2. L-Threonine
      3. Others
    2. Threonine Acids Market, By Sources, 2021 - 2031 (USD Million)
      1. Animal Based
      2. Plant Based
    3. Threonine Acids Market, By Livestock, 2021 - 2031 (USD Million)
      1. Cattle
      2. Swine
      3. Poultry
      4. Aquatic Animal
      5. Others
    4. Threonine Acids Market, By Application, 2021 - 2031 (USD Million)

      1. Food & Dietary Supplements

      2. Animal Feed

      3. Pharmaceuticals

      4. Others

    5. Threonine Acids Market, By Geography, 2021 - 2031 (USD Million)
      1. North America
        1. United States
        2. Canada
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Nordic
        7. Benelux
        8. Rest of Europe
      3. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia & New Zealand
        5. South Korea
        6. ASEAN(Association of South East Asian Countries)
        7. Rest of Asia Pacific
      4. Middle East & Africa
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa
      5. Latin America
        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
  6. Competitive Landscape
    1. Company Profiles
      1. Prinova Group LLC
      2. Evonik Industries Corporation
      3. Archer D&O Pharmachem Inc.,
      4. Degussa Corporation
      5. Shanghai Seebio Biotech, Inc.,
      6. The Graymor Chemical Co.
      7. Pharmline Inc.,
      8. Yore Chemipharm Co., Ltd.,
      9. Foodchem International Corporation,
      10. Viachem Ltd.,
      11. Peptides International Inc.,
      12. Ajinomoto Heartland, Inc.,
      13. Biomatik Corporation,
  7. Analyst Views
  8. Future Outlook of the Market